CHATPRIVACYDONATELOGINREGISTER
DMT-Nexus
FAQWIKIHEALTH & SAFETYARTATTITUDEACTIVE TOPICS
PREV123
No MAOI: Complexing DMT freebase for sublingual administration Options
 
downwardsfromzero
#41 Posted : 5/21/2020 10:23:32 PM

No way ticket

Chemical expertSenior Member

Posts: 5031
Joined: 30-Aug-2008
Last visit: 26-Sep-2020
Location: square root of minus one
Strictly speaking, yuremamine is not a 'complexed' form of DMT. The DMT is chemically bound to a flavanol moiety. (A relevant analogy might be the C-C bonding in certain flavonoid glycosides, such as vitexin and orientin.)

Since we have no particular evidence of the pharmacological activity of yuremamine, nor whether it decomposes into DMT at extremes of pH, clearly there is some more research to be done. 12mg yuremamine were recovered from 2.265 g of root bark (0.53% w/w) so it seems likely that the compound may make a contribution to the pharmacology of jurema.

For fans of systematic nomenclature, one possibility for yuremamine is 4-(3-(2-dimethylaminoethyl)indol-2-yl-2-(3,4,5-trihydroxyphenyl)-7-hydroxy-2,3-dihydro-4H-benzo[b]pyran Big grin.



Brennendes Wasser wrote:
Oh well it was late at night, I wanted to write Bioactivity Confused Big grin

Ah, bioavailability!

Ora, lege, lege, lege, relege et labora

“There is a way of manipulating matter and energy so as to produce what modern scientists call 'a field of force'. The field acts on the observer and puts him in a privileged position vis-à-vis the universe. From this position he has access to the realities which are ordinarily hidden from us by time and space, matter and energy. This is what we call the Great Work."
― Jacques Bergier, quoting Fulcanelli
 

STS is a community for people interested in growing, preserving and researching botanical species, particularly those with remarkable therapeutic and/or psychoactive properties.
 
PREV123
 
Users browsing this forum
Guest

DMT-Nexus theme created by The Traveler
This page was generated in 0.019 seconds.